The new web-based platform tool collects and analyzes post-mortem data across farms, complexes and within production companies RAHWAY, N.J., April 8, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the introduction of FLOCKSECURE™ poultry health portal, an innovative web-based platform solution designed to capture, maintain, distribute and analyze data from post-mortem sessions. Designed for the broiler industry, FLOCKSECURE provides a seamless solution to collect ..read more

Leading-edge technology provides 24/7 monitoring for better and more labor-efficient calf management RAHWAY, N.J., April 3, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the introduction of SENSEHUB® Dairy Youngstock, the industry’s first monitoring technology for dairy calves from birth through the first 12 months of life. New SENSEHUB Dairy Youngstock makes it easier for dairy producers to detect and locate calves and heifers that need attention. Proprietary, s ..read more

Agreement brings innovative solutions to address emerging disease challenges RAHWAY, N.J., April 1, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has entered into an agreement with Cambridge Technologies, an independent custom vaccine company based in Worthington, Minn., to sell and market its innovative autogenous poultry vaccines in the United States. Cambridge Technologies uses cutting-edge molecular diagnostic and manufacturing techniques to develop custom ..read more

The innovative SEQUIVITY technology provides swine producers with a safe, flexible vaccine platform to tackle existing and evolving disease challenges RAHWAY, N.J., March 20, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has received license approval from the U.S. Department of Agriculture (USDA) for SEQUIVITY® with Microsol Diluvac Forte® (MDF) adjuvant prescription vaccine for use in gilts and sows. The vaccine utilizes the innovative RNA Particle Technology ..read more

The updated stationary reader platform connects up to six antennas for improved performance to evaluate fish passage and movement RAHWAY, N.J., March 18, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the introduction of the BIOMARK® IS1001 MUX multiplexing transceiver. This updated stationary reader platform connects up to six separate antennas to deliver superior performance for the assessment of fish movement and passage in riverine environments.   &n ..read more

Student scholarship program inspires students to further their veterinary education RAHWAY, N.J., Feb. 28, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced its continued commitment to the swine industry’s next generation of veterinarians by partnering with the American Association of Swine Veterinarians Foundation (AASVF) to sponsor the 2024 recipients of the AASVF and Merck Animal Health Veterinary Student Scholarship Program. Scholarships totaling $50,000 were awa ..read more

Novel vaccine provides protection in poultry flocks against the challenges from MD, ILT and IBD in a single injection RAHWAY, N.J., Feb. 2, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that INNOVAX®-ILT-IBD vaccine is commercially available as part of its poultry product portfolio. The company received license approval for the vaccine in the U.S. from the Department of Agriculture (USDA) in 2023. INNOVAX-ILT-IBD provides combined protection and immunization agai ..read more

Rahway, NJ, January  24, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities at the International Production and Processing Expo (IPPE) in Atlanta, GA from January 30 – February 1, 2024. The company’s booth (#B7045) will feature live demonstrations of SenseHub™ Poultry, a wireless system that collects and analyzes real-tim ..read more

The award marks the 6th year in a row for recognition in this category. RAHWAY, N.J., Jan. 18, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced CIRCUMVENT® CML has been awarded the Best New Food Animal Product from S&P Global Animal Health. It is the first and only ready-to-use, single-dose intramuscular injectable vaccine against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae and Lawsonia intracellularis in pigs, three weeks of a ..read more

More veterinary professionals are provided access to and are pursuing mental health resources for their overall wellbeing with continued improvements on the horizon. RAHWAY, N.J., Jan. 15, 2024 – Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration with the American Veterinary Medical Association (AVMA). The latest study, which examined the wellbeing and mental health of U.S. veterinarians and supp ..read more